These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34655706)

  • 1. Comparative in vitro release testing (IVRT) of acyclovir products.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2021 Nov; 609():121186. PubMed ID: 34655706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
    Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
    Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
    Mohammed YH; Namjoshi SN; Jung N; Windbergs M; Benson HAE; Grice JE; Raney SG; Roberts MS
    Pharm Res; 2024 Jul; 41(7):1507-1520. PubMed ID: 38955999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2018 Jan; 535(1-2):217-227. PubMed ID: 28935255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
    Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
    Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kulkarni M; Potdar S; Date AA; Marfatiya A
    Assay Drug Dev Technol; 2021; 19(2):75-84. PubMed ID: 33035072
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2014 Aug; 15(4):994-9. PubMed ID: 24824173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are European marketed acyclovir 5% cream products similar? Comparison with EU and US reference product.
    Miron DS; Rădulescu FȘ; Voicu VA; Mînea A; Cardot JM; Shah VP
    Drug Dev Ind Pharm; 2021 Jun; 47(6):990-1000. PubMed ID: 34279163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of critical formulation parameters affecting the in vitro release, permeation, and rheological properties of the acyclovir topical cream.
    Kamal NS; Krishnaiah YSR; Xu X; Zidan AS; Raney S; Cruz CN; Ashraf M
    Int J Pharm; 2020 Nov; 590():119914. PubMed ID: 32979451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological and
    Miron DS; Rădulescu FȘ; Voicu VA; Mînea A; Cardot JM; Shah VP
    Pharm Dev Technol; 2021 Sep; 26(7):779-787. PubMed ID: 34165370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.
    Pensado A; Chiu WS; Cordery SF; Rantou E; Bunge AL; Delgado-Charro MB; Guy RH
    Pharm Res; 2019 Nov; 36(12):180. PubMed ID: 31728737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
    Xu X; Al-Ghabeish M; Rahman Z; Krishnaiah YS; Yerlikaya F; Yang Y; Manda P; Hunt RL; Khan MA
    Int J Pharm; 2015 Sep; 493(1-2):412-25. PubMed ID: 26231106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of performance matrix for generic product equivalence of acyclovir topical creams.
    Krishnaiah YS; Xu X; Rahman Z; Yang Y; Katragadda U; Lionberger R; Peters JR; Uhl K; Khan MA
    Int J Pharm; 2014 Nov; 475(1-2):110-22. PubMed ID: 25089511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
    Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
    Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence.
    Bodenlenz M; Tiffner KI; Raml R; Augustin T; Dragatin C; Birngruber T; Schimek D; Schwagerle G; Pieber TR; Raney SG; Kanfer I; Sinner F
    Clin Pharmacokinet; 2017 Jan; 56(1):91-98. PubMed ID: 27539717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams.
    Wellington H; Rath S; Kanfer I
    Eur J Pharm Sci; 2024 Jan; 192():106649. PubMed ID: 37992910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach.
    Rath S; Kanfer I
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are all aciclovir cream formulations bioequivalent?
    Trottet L; Owen H; Holme P; Heylings J; Collin IP; Breen AP; Siyad MN; Nandra RS; Davis AF
    Int J Pharm; 2005 Nov; 304(1-2):63-71. PubMed ID: 16139970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence study of generic acyclovir compared with the brand name acyclovir.
    Rojanasthien N; Teekachunhatean S; Kumsorn B; Chaichana N; Hay YK
    J Med Assoc Thai; 2002 Oct; 85(10):1121-9. PubMed ID: 12501905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.